Table 4.
Females only | ||||||||
---|---|---|---|---|---|---|---|---|
Males only | Placebo |
45.39 (26.02, 64.96) |
83.93 (51.04, 117.00) |
21.06 (7.11, 34.99) |
19.41 (0.83, 37.88) |
−1.47 (−22.03, 19.02) |
17.83 (−1.72, 37.39) |
20.09 (−2.59, 43.13) |
19.07 (7.38, 30.93) |
Risperidone 1–3 mg/day |
38.41 (3.66, 73.84) |
−24.38 (−48.30, −0.35) |
−26.03 (−52.87, 1.00) |
−46.86 (−75.20, −18.82) |
−27.58 (−55.01, −0.15) |
−25.30 (−55.39, 4.43) |
|
29.46 (17.20, 41.73) |
10.36 (−2.01, 22.94) |
Risperidone 4–6 mg/day |
−62.85 (−98.96, −27.00) |
−64.48 (−102.70, −26.72) |
−85.25 (−124.90, −46.32) |
−66.09 (−104.50, −27.90) |
−63.70 (−103.40, −24.08) |
|
−2.70 (−8.97, 3.59) |
−21.83 (−35.26, −8.46) |
−32.17 (−46.08, −18.40) |
Quetiapine 400 mg/day |
−1.69 (−17.11, 13.71) |
−22.52 (−47.18, 2.14) |
−3.20 (−27.30, 20.91) |
−0.90 (−27.88, 25.88) |
|
2.81 (−2.95, 8.54) |
−16.27 (−29.36, −3.18) |
−26.65 (−40.29, −13.13) |
5.54 (−0.04, 11.05) |
Quetiapine 800 mg/day |
−20.80 (−48.43, 6.66) |
−1.48 (−28.68, 25.29) |
0.67 (−28.60, 29.87) |
|
3.04 (−4.82, 10.87) |
−16.05 (−30.30, −2.08) |
−26.43 (−41.22, −11.94) |
5.71 (−4.30, 15.74) |
0.23 (−9.52, 9.86) |
Paliperidone 1.5 mg/day |
19.32 (−7.47, 45.84) |
21.50 (−7.73, 50.80) |
|
22.18 (10.88, 33.43) |
3.04 (−13.14, 19.30) |
−7.33 (−23.97, 9.28) |
24.87 (11.96, 37.86) |
19.35 (6.66, 31.87) |
19.16 (6.50, 31.75) |
Paliperidone 3–6 mg/day |
2.32 (−25.95, 31.03) |
|
20.61 (9.40, 32.00) |
1.54 (−14.70, 17.62) |
−8.87 (−25.30, 7.58) |
23.35 (10.46, 36.24) |
17.82 (5.19, 30.41) |
17.59 (4.98, 30.30) |
−1.52 (−16.40, 13.56) |
Paliperidone 6–12 mg/day |
The results of the fixed effects NMA are displayed. Data are presented as mean difference (95% credible interval). Values correspond to the mean differences in the column versus the row for the upper triangle and the mean differences in the row versus the column for the lower triangle. Values in bold are those differences that are statistically important.